Article Details

Key Analysts at RBC Capital Reconfirmed their 'Hold' rating for PTC Therapeutics (NASDAQ:PTCT ...

Retrieved on: 2018-01-09 02:56:15

Tags for this article:

Click the tags to see associated articles and topics

Key Analysts at RBC Capital Reconfirmed their 'Hold' rating for PTC Therapeutics (NASDAQ:PTCT .... View article details on hiswai:

Excerpt

<div><b>Millennium Management</b> Limited Liability Company owns 260,633 shares. Zurcher Kantonalbank (Zurich Cantonalbank) holds 0% of its portfolio in PTC Therapeutics, Inc. (NASDAQ:PTCT) for 1,370 shares. Hanseatic Mngmt Services Inc, New Mexico-based fund reported 105 shares. Sectoral Asset ...</div>

Article found on:

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up